Cannabis-investment stock Nabis’s 9,500% rally in peril as trades cancelled

Micro-cap Nabis Holdings Inc. surged from a penny to nearly a dollar over the course of a week before the stock was halted. Now a Canadian regulator says it will nix all those trades.

The Investment Industry regulatory Organization of Canada said all trades between Jan. 27 and Feb. 2 would be cancelled. Short-selling was also ruled ineligible.

“IIROC has made this designation in the interest of maintaining a fair and orderly market based on the fails relative to the number of shares outstanding,” read a statement.

IIROC and Nabis didn’t immediately respond to requests for comment. Nabis is a Vancouver-based investment company focused on the cannabis sector.

Nabis completed a recapitalization last month under Canada’s bankruptcy act, and issued 3.7 million new shares along with some new unsecured notes, according to a statement.

The Canadian Securities exchange said in a bulletin that Nabis’s newly issued common shares posted for trading on Jan. 27 “were not eligible for trading and trade settlement is not possible.”

Nabis’s new shares and unsecured notes will stay halted until confirmation of their eligibility, and its new common shares may not be able to trade until on or about March 1, the CSE added.

Canadian-focused cannabis stocks have been on a tear, with the Horizons Marijuana Life Sciences Index ETF up 73 per cent this year.

Nabis said this week that one of its companies, Perpetual Healthcare Inc., got a dual licence in Arizona to sell cannabis products. Nabis’s market value sits at $3.6 million after its surge.